Zhonghui Biotech expects revenue for fiscal year 2025 to increase approximately 71.8%–89.9% year-over-year

2026-02-28 00:59:45

Beijing Business Daily News (Reporter Wang Yinhao and Song Yuying) February 26 — Zhonghui Biological announced its earnings forecast, expecting to achieve operating revenue of 446 million to 493 million yuan in fiscal year 2025, an increase of approximately 71.8% to 89.9% compared to the same period in 2024; it is also expected to record a net loss of about 157 million to 197 million yuan, a reduction of approximately 23.9% to 39.3% compared to the net loss of 259 million yuan in the same period in 2024.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes